Dietary fatty acids and cardiovascular disease: A review

Detalhes bibliográficos
Autor(a) principal: Prates, Raquel Eccel
Data de Publicação: 2015
Outros Autores: Von Frankenberg, Anize Delfino, Rodrigues, Ticiana da Costa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/56681
Resumo: Fatty acids (FAs) can be classified into saturated (SFA), unsaturated (poly- or monounsaturated) and trans FA. Recent studies have found that both the quantity and quality of dietary FAs may influence their role in metabolic pathways. Due to their chemical composition, some FAs play a major role in the development and progression of cardiovascular disease. This is especially true for SFA and n-3 polyunsaturated fatty acids, which include marine eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The proinflammatory effects of high SFA intake may increase the risk of atherosclerosis. On the other hand, dietary n-3 intake may reduce the risk of cardiovascular disease by decreasing atherosclerosis, inflammation, and thrombotic processes. The goal of this study was to review the current literature on the role of FA intake in the prevention and risk of cardiovascular disease.   
id UFRGS-20_0668b4501e2bfe677576274787fef171
oai_identifier_str oai:seer.ufrgs.br:article/56681
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Dietary fatty acids and cardiovascular disease: A reviewFatty acidscardiovascular diseaseFatty acidsFatty acids (FAs) can be classified into saturated (SFA), unsaturated (poly- or monounsaturated) and trans FA. Recent studies have found that both the quantity and quality of dietary FAs may influence their role in metabolic pathways. Due to their chemical composition, some FAs play a major role in the development and progression of cardiovascular disease. This is especially true for SFA and n-3 polyunsaturated fatty acids, which include marine eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The proinflammatory effects of high SFA intake may increase the risk of atherosclerosis. On the other hand, dietary n-3 intake may reduce the risk of cardiovascular disease by decreasing atherosclerosis, inflammation, and thrombotic processes. The goal of this study was to review the current literature on the role of FA intake in the prevention and risk of cardiovascular disease.   HCPA/FAMED/UFRGS2015-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliados por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/56681Clinical & Biomedical Research; Vol. 35 No. 3 (2015): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 35 n. 3 (2015): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/56681/pdf_19Prates, Raquel EccelVon Frankenberg, Anize DelfinoRodrigues, Ticiana da Costainfo:eu-repo/semantics/openAccess2024-01-19T14:26:16Zoai:seer.ufrgs.br:article/56681Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:26:16Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Dietary fatty acids and cardiovascular disease: A review
title Dietary fatty acids and cardiovascular disease: A review
spellingShingle Dietary fatty acids and cardiovascular disease: A review
Prates, Raquel Eccel
Fatty acids
cardiovascular disease
Fatty acids
title_short Dietary fatty acids and cardiovascular disease: A review
title_full Dietary fatty acids and cardiovascular disease: A review
title_fullStr Dietary fatty acids and cardiovascular disease: A review
title_full_unstemmed Dietary fatty acids and cardiovascular disease: A review
title_sort Dietary fatty acids and cardiovascular disease: A review
author Prates, Raquel Eccel
author_facet Prates, Raquel Eccel
Von Frankenberg, Anize Delfino
Rodrigues, Ticiana da Costa
author_role author
author2 Von Frankenberg, Anize Delfino
Rodrigues, Ticiana da Costa
author2_role author
author
dc.contributor.author.fl_str_mv Prates, Raquel Eccel
Von Frankenberg, Anize Delfino
Rodrigues, Ticiana da Costa
dc.subject.por.fl_str_mv Fatty acids
cardiovascular disease
Fatty acids
topic Fatty acids
cardiovascular disease
Fatty acids
description Fatty acids (FAs) can be classified into saturated (SFA), unsaturated (poly- or monounsaturated) and trans FA. Recent studies have found that both the quantity and quality of dietary FAs may influence their role in metabolic pathways. Due to their chemical composition, some FAs play a major role in the development and progression of cardiovascular disease. This is especially true for SFA and n-3 polyunsaturated fatty acids, which include marine eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The proinflammatory effects of high SFA intake may increase the risk of atherosclerosis. On the other hand, dietary n-3 intake may reduce the risk of cardiovascular disease by decreasing atherosclerosis, inflammation, and thrombotic processes. The goal of this study was to review the current literature on the role of FA intake in the prevention and risk of cardiovascular disease.   
publishDate 2015
dc.date.none.fl_str_mv 2015-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliados por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/56681
url https://seer.ufrgs.br/index.php/hcpa/article/view/56681
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/56681/pdf_19
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 35 No. 3 (2015): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 35 n. 3 (2015): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767053734772736